Kelly Page

Kelly Page currently serves as Senior Vice President and Global Head of Oncology Strategy and Program Leadership at Arvinas, where responsibilities include driving the development strategy and overseeing the clinical oncology pipeline. Prior to this role, Kelly was Vice President and Global Commercial Head for Hematology at AstraZeneca, focusing on commercialization efforts and promoting a culture of inclusion. With extensive experience at Takeda Oncology, Kelly held various leadership positions, including Head of Global Cell Therapy Commercialization and Oncology Country Head, where strategic development and execution were priorities. Additionally, early career roles at Pfizer encompassed worldwide marketing and project management in oncology. Kelly holds a Bachelor of Science in Biology and a Bachelor of Arts in Chemistry from Providence College, as well as an MBA from the University of Rhode Island.